Menu Search
Equities

Nihon Chouzai Co Ltd

3341:TYO

Nihon Chouzai Co Ltd

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (JPY)1,345.00
  • Today's Change13.00 / 0.98%
  • Shares traded11.00k
  • 1 Year change+4.51%
  • Beta0.4116
Data delayed at least 20 minutes, as of Nov 15 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 16-Nov-23
  • 15-Aug-24
  • 19-Sep-24
  • 17-Oct-24
  • 07-Nov-24
Select bar for recommendation details.
Recommendations07-Nov-24
Buy0
Outperform0
Hold2
Sell0
Strong Sell0

Share price forecast in JPY

The 2 analysts offering 12 month price targets for Nihon Chouzai Co Ltd have a median target of 1,560.00, with a high estimate of 1,620.00 and a low estimate of 1,500.00. The median estimate represents a 15.99% increase from the last price of 1,345.00.
High20.4%1,620.00
Med16.0%1,560.00
Low11.5%1,500.00

Dividends in JPY

In 2024, Nihon Chouzai Co Ltd reported a dividend of 25.00 JPY, equaling last years dividend. The 2 analysts covering the company expect dividends of 25.00 JPY for the upcoming fiscal year, maintaining dividends from this year.
Div growth (TTM)0.00%
More ▼

Earnings history & estimates in JPY

Nihon Chouzai Co Ltd reported annual 2024 earnings of 85.35 per share on Apr 30, 2024.
Average growth rate-16.15%
More ▼

Revenue history & estimates in JPY

Nihon Chouzai Co., Ltd. had 2nd quarter 2025 revenues of 89.14m. This missed the 92.82m consensus estimate of the 2 analysts following the company. This was 8.91% above the prior year's 2nd quarter results.
Average growth rate+1.38%
Nihon Chouzai Co., Ltd. had revenues for the full year 2024 of 340.31m. This was 8.61% above the prior year's results.
Average growth rate+6.12%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.